Detalles de la búsqueda
1.
Immunochemotherapy for visceral leishmaniasis: combinatorial action of Miltefosine plus LBSapMPL vaccine improves adaptative Th1 immune response with control of splenic parasitism in experimental hamster model.
Parasitology;
149(3): 371-379, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264268
2.
Recent advances and new strategies in Leishmaniasis diagnosis.
Appl Microbiol Biotechnol;
104(19): 8105-8116, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32845368
3.
Liver infusion tryptose (LIT): the best choice for growth, viability, and infectivity of Leishmania infantum parasites.
Parasitol Res;
119(12): 4185-4195, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33033848
4.
The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection.
Vaccines (Basel);
11(2)2023 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851272
5.
Immunoprophylaxis using polypeptide chimera vaccines plus adjuvant system promote Th1 response controlling the spleen parasitism in hamster model of visceral leishmaniasis.
Vaccine;
40(37): 5494-5503, 2022 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963820
6.
Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.
Mol Immunol;
141: 70-78, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34814056
7.
A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice.
Vaccine;
39(20): 2755-2763, 2021 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33875268
8.
Heterologous vaccine therapy associated with half course of Miltefosine promote activation of the proinflammatory response with control of splenic parasitism in a hamster model of visceral leishmaniasis.
Curr Res Immunol;
2: 194-201, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35492387
9.
Corrigendum: Kinetics of Phenotypic and Functional Changes in Mouse Models of Sponge Implants: Rational Selection to Optimize Protocols for Specific Biomolecules Screening Purposes.
Front Bioeng Biotechnol;
9: 660117, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748096
10.
Phase I and II Clinical Trial Comparing the LBSap, Leishmune®, and Leish-Tec® Vaccines against Canine Visceral Leishmaniasis.
Vaccines (Basel);
8(4)2020 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33212786
11.
Labeling PLA-PEG nanocarriers with IR780: physical entrapment versus covalent attachment to polylactide.
Drug Deliv Transl Res;
10(6): 1626-1643, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32613549
12.
Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T Cells That Trigger Protection against Experimental Visceral Leishmaniasis.
Vaccines (Basel);
8(2)2020 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471081
13.
Kinetics of Phenotypic and Functional Changes in Mouse Models of Sponge Implants: Rational Selection to Optimize Protocols for Specific Biomolecules Screening Purposes.
Front Bioeng Biotechnol;
8: 538203, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33344427
14.
In vitro Infectivity of Strains Isolated From Dogs Naturally Infected With Leishmania infantum Present a Distinct Pathogenic Profile in Hamsters.
Front Med (Lausanne);
7: 496, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32984376
15.
Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and Incomplete Freund's Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation.
Vaccine;
37(49): 7269-7279, 2019 11 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31575491
16.
Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice.
Vaccines (Basel);
7(4)2019 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31661776
17.
A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden.
Front Immunol;
8: 217, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28321217
18.
Association between mast cells, tissue remodelation and parasite burden in the skin of dogs with visceral leishmaniasis.
Vet Parasitol;
243: 260-266, 2017 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807304
19.
Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.
Parasit Vectors;
9: 472, 2016 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27577735
20.
Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
PLoS One;
11(8): e0161169, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27556586